Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor

Objectives: Farnesoid X receptor (FXR) activation is involved in ameliorating inflammatory bowel disease (IBD), such as ulcerative colitis (UC), and inflammatory regulation may be involved in its mechanism. Ginsenoside Rc (Rc) is a major component of Panax ginseng, and it plays an excellent role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kaijia, Kong, Danli, Peng, Yuan, Guo, Jingyi, Zhong, Yadi, Yu, Haibing, Mai, Zhenhua, Chen, Yanling, Chen, Yingjian, Cui, Tianqi, Duan, Siwei, Li, Tianyao, Liu, Naihua, Zhang, Dong, Ding, Yuanlin, Huang, Jiawen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649634/
https://www.ncbi.nlm.nih.gov/pubmed/36386150
http://dx.doi.org/10.3389/fphar.2022.1000444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649634/
https://www.ncbi.nlm.nih.gov/pubmed/36386150
http://dx.doi.org/10.3389/fphar.2022.1000444

Ejemplares similares